Show simple item record

dc.contributor.authorBozkurt, MF
dc.contributor.authorVirgolini, I
dc.contributor.authorBalogova, S
dc.contributor.authorBeheshti, M
dc.contributor.authorRubello, D
dc.contributor.authorDecristoforo, C
dc.contributor.authorAmbrosini, V
dc.contributor.authorKjaer, A
dc.contributor.authorDelgado-Bolton, R
dc.contributor.authorKunikowska, J
dc.contributor.authorOyen, WJG
dc.contributor.authorChiti, A
dc.contributor.authorGiammarile, F
dc.contributor.authorSundin, A
dc.contributor.authorFanti, S
dc.date.accessioned2018-02-14T16:06:43Z
dc.date.issued2017-08
dc.identifier.citationEuropean journal of nuclear medicine and molecular imaging, 2017, 44 (9), pp. 1588 - 1601
dc.identifier.issn1619-7070
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1089
dc.identifier.eissn1619-7089
dc.identifier.doi10.1007/s00259-017-3728-y
dc.description.abstractPurpose & methods Neuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic options. This guideline is aimed to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin receptor (SSTR) PET/CT imaging using 68 Ga-DOTA-conjugated peptides, as well as 18 F-DOPA imaging for various neuroendocrine neoplasms.Results & conclusion The previous procedural guideline by EANM regarding the use PET/CT tumour imaging with 68 Ga-conjugated peptides has been revised and updated with the relevant and recent literature in the field with contribution of distinguished experts.
dc.formatPrint-Electronic
dc.format.extent1588 - 1601
dc.languageeng
dc.language.isoeng
dc.subjectHumans
dc.subjectNeuroendocrine Tumors
dc.subjectGallium Radioisotopes
dc.subjectDihydroxyphenylalanine
dc.subjectHeterocyclic Compounds, 1-Ring
dc.subjectPeptides
dc.subjectReceptors, Somatostatin
dc.subjectImage Interpretation, Computer-Assisted
dc.subjectTissue Distribution
dc.subjectQuality Control
dc.subjectPractice Guidelines as Topic
dc.subjectPositron Emission Tomography Computed Tomography
dc.titleGuideline for PET/CT imaging of neuroendocrine neoplasms with <sup>68</sup>Ga-DOTA-conjugated somatostatin receptor targeting peptides and <sup>18</sup>F-DOPA.
dc.typeJournal Article
dcterms.dateAccepted2017-05-09
rioxxterms.versionofrecord10.1007/s00259-017-3728-y
rioxxterms.licenseref.startdate2017-08
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfEuropean journal of nuclear medicine and molecular imaging
pubs.issue9
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Molecular Imaging
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Molecular Imaging
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume44
pubs.embargo.termsNot known
icr.researchteamTranslational Molecular Imagingen_US
dc.contributor.icrauthorOyen, Willemen
dc.contributor.icrauthorMarsden,en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record